Poly-N-acetyllactosamines are attached to N-glycans, O-glycans, and glycolipids and serve as underlying glycans that provide functional oligosaccharides such as sialyl Lewis X . Poly-N-acetyllactosaminyl repeats are synthesized by the alternate addition of ␤1,3-linked GlcNAc and ␤1,4-linked Gal by i-extension enzyme (iGnT) and a member of the ␤1,4-galactosyltransferase (␤4Gal-T) gene family. In the present study, we first found that poly-N-acetyllactosamines in N-glycans are most efficiently synthesized by ␤4Gal-TI and iGnT. We also found that iGnT acts less efficiently on acceptors containing increasing numbers of N-acetyllactosamine repeats, in contrast to ␤4Gal-TI, which exhibits no significant change. In O-glycan biosynthesis, N-acetyllactosamine extension of core 4 branches was found to be synthesized most efficiently by iGnT and ␤4Gal-TI, in contrast to core 2 branch synthesis, which requires iGnT and ␤4Gal-TIV. Poly-N-acetyllactosamine extension of core 4 branches is, however, less efficient than that of N-glycans or core 2 branches. Such inefficiency is apparently due to competition between a donor substrate and acceptor in both galactosylation and N-acetylglucosaminylation, since a core 4-branched acceptor contains both Gal and GlcNAc terminals. These results, taken together, indicate that poly-N-acetyllactosamine synthesis in N-glycans and core 2-and core 4-branched Oglycans is achieved by iGnT and distinct members of the ␤4Gal-T gene family. The results also exemplify intricate interactions between acceptors and specific glycosyltransferases, which play important roles in how poly-Nacetyllactosamines are synthesized in different acceptor molecules.
Poly-N-acetyllactosamines are unique glycans having N-acetyllactosamine repeats (Gal␤134GlcNAc␤133) n in one side chain (1) . Poly-N-acetyllactosamines are attached to Nglycans (2-4), O-glycans (5-7), and glycolipids (8 -10) . Poly-Nacetyllactosamines are often modified to express differentiation antigens and functional oligosaccharides. One of those oligosaccharides is sialyl Le X , 1 NeuNAc␣233Gal␤134(Fuc␣133)-GlcNAc3 R discovered in human granulocytes and monocytes (11, 12) . Sialyl Le X and its sulfated forms, such as 6-sulfo sialyl Le X , NeuNAc␣233Gal␤134[Fuc␣133(sulfo36)]GlcNAc3 R in mucin-type glycoproteins, have been shown to be ligands for E-, P-, and L-selectin (13) (14) (15) .
Since these O-glycans are present as clusters in mucin-type glycoproteins, mucin-type glycoproteins can present multiple ligands to a selectin. In mucin-type glycoproteins of blood cells, sialyl Le X can be found in core 2-branched oligosaccharides (5, 6, 16) . Similarly, 6-sulfo sialyl Le X in L-selectin ligands found in high endothelial venules are synthesized in core 2-branched oligosaccharides such as NeuNAc␣233Gal␤134[Fuc␣133-(sulfo36)]GlcNAc␤136(Gal␤133)GalNAc␣13serine/threonine (17) (18) (19) .
The enzyme responsible for core 2 branching is called core 2 ␤1,6-N-acetylglucosaminyltransferase (C2GnT), and its cDNA has been cloned (20) . When C2GnT was inactivated by gene targeting, leukocytes from those mutant mice exhibit much reduced binding to P-, L-, and E-selectin, although the effect on E-selectin binding was less severe than binding to P-and L-selectin (21) .
In the gastrointestinal tract, oligosaccharides with core 3, GlcNAc␤133GalNAc, can be frequently found (22) . In these tissues, core 3 is converted to core 4 by core 4 ␤1,6-N-acetylglucosaminyltransferase (C4GnT), forming Gal␤134GlcNAc␤-136(GlcNAc␤133)GalNAc (23, 24) .
Recently, we and others have cloned cDNA encoding C4GnT (25, 26) . This enzyme is unique in having a major C2GnT activity and a minor I branching activity in addition to C4GnT activity. The expression profile of this novel C2/C4/IGnT (termed C2GnT-mucin type) is consistent with the expression profile of core 4 oligosaccharides in various tissues (22, 25) . In these tissues, C4GnT activity is always associated with C2GnT activity, suggesting that C2GnT-mucin type is probably the enzyme responsible for the formation of core 4-branched oligosaccharides in these tissues. Since core 4 oligosaccharides can be further modified to express sialyl Le X in N-acetyllactosaminyl side chains, the synthesis of core 4 and its poly-N-acetyllactosaminyl extension provide a basis for the formation of functional oligosaccharides.
These results indicate that it is crucial to understand the synthesis of N-acetyllactosamine repeats in core 2-or core 4-branched O-glycans as well as in N-glycans. To this end, we have previously demonstrated (27) that poly-N-acetyllactosamines in core 2-branched O-glycans are synthesized with a newly discovered member of ␤1,4-galactosyltransferase, ␤4Gal-TIV (28) and a newly cloned i-extension enzyme (iGnT) (29) . We have also found that ␤4Gal-TI, iGnT, and I-branching enzyme (IGnT) are involved in the synthesis of I-branched poly-Nacetyllactosamines (30) . In the same study, we found that the addition of N-acetyllactosamine repeats to linear N-acetyllactosamine is preferred over the extension of N-acetyllactosamine to an I branch, mainly because galactosylation of a GlcNAc␤136 branch is inefficient (30) . Third, we demonstrated that similar size and similar amounts of poly-Nacetyllactosamine are synthesized in both side chains of GlcNAc␤136(GlcNAc␤132)Man␣136Man␤13 R, which was preformed by the action of N-acetylglucosaminyltransferase V. We found that this equal distribution of poly-N-acetyllactosamines is achieved because ␤4Gal-TI and iGnT have complementary branch specificity toward two side chains (31) .
These results prompted us in the present study to determine how poly-N-acetyllactosamine synthesis is regulated in both Nand O-glycans. Our results demonstrate that ␤4Gal-TI is most efficient for poly-N-acetyllactosamine synthesis in N-glycan acceptors and that iGnT but not ␤4Gal-TI decreases its enzymatic activity as acceptors contain increasing numbers of N-acetyllactosamine repeats. We also demonstrated that ␤4Gal-TI predominantly galactosylates core 4-branched O-glycans. Moreover, we found that fewer N-acetyllactosamine extensions can be formed on core 4-than on core 2-branched oligosaccharides, mainly because iGnT is inefficient on core 4-branched acceptors.
EXPERIMENTAL PROCEDURES

Isolation and Expression of cDNA Encoding iGnT-
The cDNA encoding iGnT was cloned into pcDNA3.1, resulting in pcDNA3.1-iGnT as described previously (29) . pcDNAI-A, harboring cDNA encoding a signal sequence and an IgG binding domain of Staphylococcus aureus protein A, was constructed as described before (32) . The catalytic domain of iGnT was cloned into this vector, resulting in pcDNAI-A⅐iGnT (29) .
pcDNAI-A and pcDNAI-A⅐iGnT were separately transfected with LipofectAMINE Plus (Life Technologies) into COS-1 cells as described previously (29) . The chimeric enzyme released into serum-free OPTI-MEM was used after adsorbing the protein A chimeric enzyme to IgG-Sepharose 6FF (Amersham Pharmacia Biotech) as described previously (33) . Alternatively, the culture medium was concentrated 100-or 1,000-fold by a Centricon 10 concentrator (Amicon) and directly used as an enzyme source. In most of the studies, the concentrated culture medium was used for iGnT, since IgG-Sepharose-bound enzymes had a low activity as seen for other glycosyltransferases (34, 35) . Typically, the activity of iGnT in the incubation mixture was 38.0 nmol/h/ml (for the addition of one GlcNAc) or 380.0 nmol/h/ml (for poly-N-acetyllactosamine synthesis), using 0.5 mM Gal␤134Glc␤13p-nitrophenol (Toronto Research Chemicals) as an acceptor. The medium from mocktransfected COS-1 cells contained less than one-fifth of iGnT activity compared with that derived from pcDNAI-A⅐iGnT-transfected COS-1 cells, as described (29) .
Expression of cDNAs Encoding ␤4Gal-TII, -TIII, -TIV, and -TV␤4Gal-TII, -TIII, and -TIV were expressed in insect cells, and the supernatants from these transfected insect cells were used as an enzyme source as described previously (27, 28, 36) . .0 nmol/h/ml (for ␤4Gal-Ts), determined using 0.5 mM GlcNAc␤13p-nitrophenol, or 380.0 nmol/h/ml (for iGnT), determined using 0.5 mM Gal␤134Glc␤13p-nitrophenol, was present in these experiments. preparation (Sigma) was directly used as ␤4Gal-TI (27) . ␤4Gal-TV (37) was cloned and expressed in COS-1 cells as described previously (27) . For comparing the enzymatic activities of different ␤4Gal-T samples, the final concentration of ␤4Gal-TI, -TII, -TIII, -TIV, and -TV was adjusted to 38.0 nmol/h/ml as measured using 0.5 mM GlcNAc␤13p-nitrophenol (Sigma) as an acceptor.
Synthesis of Oligosaccharides-(Gal␤134GlcNAc␤133) n Gal␤134-GlcNAc␤136Man␣136Man␤13 O(CH 2 ) 7 CH 3 (octyl), where n ϭ 0, 1, and 2, were synthesized, starting from the derivatives of Gal␤134-GlcNAc and Man␣136Man␤13octyl, as described previously (27, 38) . GlcNAc␤133Gal␤134GlcNAc␤136Man␣136Man␤13octyl and GlcNAc␤133Gal␤134GlcNAc␤133Gal␤134GlcNAc␤136Man␣-136Man␤13octyl were prepared by Escherichia coli ␤-galactosidase (5 units; Sigma) treatment of Gal␤134GlcNAc␤133Gal␤134GlcNAc␤-136Man␣136Man␤13octyl and Gal␤134GlcNAc␤133Gal␤134 GlcNAc␤133Gal␤134GlcNAc␤136Man␣136Man␤13octyl, respectively, as described previously (27, 38) . GlcNAc␤132Man␣136Man␤-13octyl was synthesized essentially as described previously (39) .
Gal␤134GlcNAc␤136(GlcNAc␤133)GalNAc␣13octyl (compound 1) was synthesized from octyl O- (3,4,6- 
. All glycosylation reactions were performed under nitrogen in the presence of 4-Å molecular sieves and monitored by thin layer chromatography. Briefly, compound 2 was allowed to couple with compound 3 in the presence of dimethyl(methylthio)sulfoniumtriflate to furnish octyl O- (2,3,4,6- 
. After conventional deprotection of the blocking groups of compound 4 (40), the reaction mixture was finally purified over silica gel followed by LH-20 Sephadex column chromatography, resulting in compound 1.
Compound 1 was treated with E. coli ␤-galactosidase as described above and purified by a C 18 -Sep-Pak column followed by LH-20 gel filtration as described previously (27, 38) , resulting in GlcNAc␤136-(GlcNAc␤133)GalNAc␣13octyl (compound 5). In a similar fashion, Gal␤134GlcNAc␤136(Gal␤133)GalNAc␣-13octyl (compound 6) was synthesized by coupling of compound 3 with Poly-N-acetyllactosamine Synthesis by iGnT and ␤4Gal-Ts-To assay poly-N-acetyllactosamine formation, 0.5 mM acceptor was incubated with different ␤4Gal-Ts (760.0 nmol/h/ml) and iGnT (380.0 nmol/h/ml) under the conditions described previously (27, 31) . The incubation mixture was purified by a C 18 -reverse phase Sep-Pak cartridge column (Waters), and the product was analyzed by HPLC using an NH 2 -bonded silica column (Varian Micropak AX-5) as described previously (27, 30, 31) . The radioactivity of aliquots in the effluent was determined.
Peaks containing one and two N-acetyllactosamine repeats were separately digested with Escherichia freundii endo-␤-galactosidase for 18 h at 37°C (41) . The digest was purified by a Sep-Pak column and applied to a column of Bio-Gel P-2 (Ϫ400 mesh) as described previously (27) .
The Addition of Galactose by Different ␤4Gal-Ts-To assay the transfer of galactose residues by ␤4Gal-T, the reaction mixture was exactly the same as described previously (27) .
Similarly, the transfer of N-acetylglucosamine by iGnT was assayed exactly in the same way as described previously (27) .
In all of the above incubations, the reaction mixture was incubated for 10 h to analyze the products or for 1 h to obtain kinetic parameters.
RESULTS
Synthesis of Poly-N-acetyllactosamines in N-Glycans by iGnT and Different
Members of the ␤4Gal-T Family-Previously, we have shown that iGnT and ␤4Gal-TI can form poly-N-acetyllactosamines in N-glycan acceptors (27) . To determine if other members of the ␤4Gal-T family may be also involved in poly-N-acetyllactosamine formation in N-glycans, N-glycan acceptors were incubated with iGnT and different members of ␤4Gal-T.
As shown in Fig. 1 , A and F, ␤4Gal-TI together with iGnT efficiently formed poly-N-acetyllactosamines on both Gal␤134-GlcNAc␤136Man␣136Man␤13octyl and Gal␤134GlcNAc␤- 3 H]Gal. The same amount of the enzyme, 38.0 nmol/h/ml, determined using 0.5 mM GlcNAc␤13p-nitrophenol, was used.
132Man␣136Man␤13octyl. As many as four (possibly five) N-acetyllactosamine units were added to both acceptors. In contrast, together with iGnT, ␤4Gal-TII and -TIII added two N-acetyllactosamine units as a maximum, while ␤4Gal-TIV and -TV added only one N-acetyllactosamine unit (Fig. 1) . Moreover, the total amount of N-acetyllactosamine incorporation by ␤4Gal-TII, -TIII, -TIV, or -TV and iGnT was less than half of that incorporated by ␤4Gal-TI and iGnT.
␤4Gal-TII, -TIII, -TIV and -TV Are Inefficient in Galactosylation of N-Glycan Acceptors-The above results can be obtained if ␤4Gal-TII, -TIII, -TIV, and -TV are less efficient in galactosylation of the shortest acceptor containing only one N-acetylglucosamine (structure a in Fig. 2) . Alternatively, these ␤4Gal-Ts are less efficient in galactosylation of acceptors containing more than one N-acetyllactosamine unit. As shown in Fig. 2A , ␤4Gal-TI is very efficient in galactosylation of the acceptors tested and barely decreased its galactosylation efficiency when acceptors contained increasing numbers of Nacetyllactosaminyl repeats. In contrast, ␤4Gal-TIV or -TV added much less galactose to N-glycan acceptors because their K m is much higher than that for ␤4Gal-TI (Fig. 2, D and E, Table I ). Moreover, ␤4Gal-TIV significantly decreases its V max once the acceptor contains more than one N-acetyllactosamine unit (structure b in Fig. 2) , while ␤4Gal-TV has much lower V max than ␤4Gal-TI irrespective of the number of N-acetyllactosamine units present in the acceptors (Table I) . ␤4Gal-TII has as low a V max value as ␤4Gal-TV, but its K m is lower than that of ␤4Gal-TI (Table I) . Similarly, K m for ␤4Gal-TIII is lower than that of ␤4Gal-TI, but ␤4Gal-TIII has lower V max than ␤4Gal-TI (Table I) . Moreover, ␤4Gal-TIII decreases its V max significantly once the acceptor contains two N-acetyllactosamine units (structure c in Fig. 2, Table I ). These are probably the reasons why ␤4Gal-TII or ␤4Gal-TIII, together with iGnT, managed to add two N-acetyllactosamine units, although max of iGnT is compared with the V max (97.8 nmol/h/ml) obtained using Gal␤1-4GlcNAc␤1-6Man␣1-6Man␤-octyl as an acceptor.
the amount of the products was still less than that by ␤4Gal-TI and iGnT (Fig. 1) . These results, as a whole, indicate that ␤4Gal-TI is most efficient in galactosylation of poly-Nacetyllactosaminyl N-glycan acceptors as well as a single Nacetyllactosaminyl N-glycan acceptor.
iGnT Becomes Less Efficient as Acceptors Become Longer by Having N-Acetyllactosamine Repeats-
The above results explain the reason for the difference in N-acetyllactosamine formation by different ␤4Gal-Ts. On the other hand, the amount of the products containing two or more N-acetyllactosamine units was significantly less than that containing one N-acetyllactosamine unit, regardless of which ␤4Gal-T was present.
To determine if the efficiency of iGnT changes when the acceptors contain increasing numbers of N-acetyllactosamine units, (Gal␤134GlcNAc␤133) n Gal␤134GlcNAc␤136Man␣-136Man␤13octyl, where n ϭ 0, 1, or 2, was incubated with iGnT.
The results shown in Fig. 3 indicate that the efficiency of iGnT significantly decreases when the acceptor contains two N-acetyllactosamine units (structure B in Fig. 3 ; see also Table  I ). In contrast, the efficiency of ␤4Gal-TI was barely affected by the increasing size of the acceptors ( Fig. 2A, Table I ). Since ␤4Gal-TI is abundantly present in various tissues, this enzyme is judged to be sufficiently present to form poly-N-acetyllactosamines in N-glycans in various tissues. These results, combined together, indicate that the action of iGnT is most likely a rate-limiting step in poly-N-acetyllactosamine formation in N-glycans.
Poly-N-acetyllactosamine Synthesis of Core 4-Branched OGlycans-Recently, we cloned the cDNA encoding a novel C2GnT, C2GnT-mucin type (25) . This enzyme is unique in having core 4 branching activity in addition to core 2 branching activity. Since core 4 branch, GlcNAc␤136(GlcNAc␤133)-GalNAc, is galactosylated in nature to form Gal␤134-GlcNAc␤136(GlcNAc␤133)GalNAc, core 4 branches also can be further modified to form functional oligosaccharides such as sialyl Lewis X in addition to core 2 branches. It is thus important to determine if N-acetyllactosamine formation in core 4 branches is more efficient than that in core 2 branches.
As shown in Fig. 4A , ␤4Gal-TI is most efficient in galactosylation of core 4 branches. We then incubated a galactosylated core 4 acceptor, Gal␤134GlcNAc␤136(GlcNAc␤133)GalNAc␣13octyl with iGnT and ␤4Gal-TI. As shown in Fig. 5A , core 4 was efficiently converted to those containing one or two N-acetyllactosamine units. To determine the structure of the product, peak 1 eluted at fractions 31-34 was digested with endo-␤-galactosidase. The digested product eluted at the position corresponding to Gal␤134GlcNAc␤133Gal (Fig. 5D) , indicating that one N-acetyllactosamine extension took place either at the Gal␤134GlcNAc␤136 branch or at the GlcNAc␤-133GalNAc side chain. When the peak 2 eluted at fractions 38 -40 was digested with endo-␤-galactosidase, Gal␤134-GlcNAc␤133Gal and GlcNAc␤133Gal were released (data not shown). These results indicate that peak 2 represents (*Gal␤-134*GlcNAc␤133) m Gal␤134GlcNAc␤136[(*Gal␤134*-GlcNAc␤133) n *Gal␤134GlcNAc␤133]GalNAc␣13octyl, where m ϩ n ϭ 2 and radioactive sugars are labeled by asterisks.
The efficient addition of one or two N- acetyllactosamine   FIG. 4 . Dependence of different members of ␤4Gal-T on the concentration of linear or core 3-or core 4-branched oligosaccharides. GlcNAc-␤136(GlcNAc␤133)GalNAc␣13octyl (A), GlcNAc␤133GalNAc␣13p-nitrophenol (B), or Gal␤134GlcNAc␤136(GlcNAc␤133)GalNAc␣13octyl (C) was incubated with 5 mM UDP-[ 3 H]Gal and ␤4Gal-TI (q), -II (‚), -TIII (Ⅺ), -TIV (E), or -TV (f). The same amount of the enzyme was used as in Fig. 2.   FIG. 5 . Analysis of the products after incubation of core 4-and core 2-branched oligosaccharide acceptors. A and C, HPLC analysis of the products derived from core 4, Gal␤134GlcNAc␤136-(GlcNAc␤133)GalNAc␣13octyl (A) and core 2, Gal␤134GlcNAc␤-136(Gal␤133)GalNAc␣13p-nitrophenol (C) after incubation with iGnT and ␤4Gal-TI. B, HPLC analysis of the products from core 2, Gal␤134GlcNAc␤136(Gal␤133)GalNAc␣13octyl after incubation with iGnT and ␤4Gal-TIV. Peaks 1 and 2 in A and B represent the products containing one (1) and two (2) N-acetyllactosamine repeats. For A-C, the incubation conditions are the same as for Fig. 1. D-F , Bio-Gel P-2 gel filtration of the products obtained after endo-␤-galactosidase digestion of peak 1 in A (D), B (E), and C (F). Peaks y and z denote the elution positions of GlcNAc␤133Gal and Gal␤134 GlcNAc␤133Gal, respectively. units was observed when the core 2-branched oligosaccharide was incubated with ␤4Gal-TIV and iGnT (Fig. 5B) . The product containing one N-acetyllactosamine unit produced Gal␤134-GlcNAc␤133Gal after endo-␤-galactosidase treatment (Fig.  5E ). On the other hand, the core 2 oligosaccharide incubated with iGnT and ␤4Gal-TI produced GlcNAc␤133Gal␤134-GlcNAc␤136(Gal␤133)GalNAc␣13p-nitrophenol and Gal␤-134GlcNAc␤133Gal␤134GlcNAc␤136(Gal␤133)GalNAc␣-13p-nitrophenol (peaks 1 and 2 in Fig. 5C ), indicating that only one N-acetyllactosamine unit was added as a maximum. The structure of peak 1 (Fig. 5F ) and peak 2 was confirmed by endo-␤-galactosidase treatment. These results confirmed the previous finding that ␤4Gal-TIV is involved in poly-N-acetyllactosamine synthesis of core 2-branched oligosaccharides (27) .
Both iGnT and ␤4Gal-TI Are Less Efficient Toward Core 4-branched Acceptors than Core 2-branched Acceptors-
The above results also demonstrate that the amount of the products from the core 4-branched acceptor incubated with ␤4Gal-TI and iGnT is less than half of that derived from the core 2-branched acceptor incubated with ␤4Gal-TIV and iGnT (Fig.  5, compare A and B) .
To determine why the core 4 oligosaccharide is a less favorable acceptor than the core 2 oligosaccharide, the iGnT and ␤4Gal-TI activities were tested on various acceptors. First, among ␤4Gal-Ts, ␤4Gal-TI worked most efficiently on GlcNAc␤133GalNAc␣13 R (Fig. 4B) . In contrast, the same enzyme worked less efficiently on Gal␤134GlcNAc␤136-(GlcNAc␤133)GalNAc␣13 R (Fig. 4C, Table II ). This is probably due to a competition between UDP-Gal and the galactose residue in Gal␤134GlcNAc␤136(GlcNAc␤133)GalNAc␣13 R. It is likely that galactosylation of the core 4 branch, GlcNAc␤-136(GlcNAc␤133)GalNAc, is also reduced once GlcNAc␤136-(Gal␤134 GlcNAc␤133)GalNAc is formed. We then tested if the iGnT is less efficient when one N-acetyllactosamine unit is present in a core 4-branched acceptor. Fig. 6 illustrates that iGnT acts less efficiently on the core 4 acceptor, Gal␤134-GlcNAc␤136(GlcNAc␤133)GalNAc␣13 R than on the core 2 acceptor, Gal␤134GlcNAc␤136(Gal␤133)GalNAc␣13 R (see also Table II ). This decrease toward the core 4-branched acceptor may also be due to competition between the N-acetylglucosamine residue in the acceptor and UDP-GlcNAc.
These results indicate that poly-N-acetyllactosamine formation on core 4-branched oligosaccharides is not efficient, most likely because acceptor structures compete with donor substrates.
DISCUSSION
The present study demonstrates that poly-N-acetyllactosaminyl extension in N-glycans is achieved mainly by ␤4Gal-TI and iGnT. Although ␤4Gal-TII and -TIII together with iGnT can also add N-acetyllactosamine repeats in N-glycans, their efficiency was less than half of that by ␤4Gal-TI and iGnT. Moreover, the products by ␤4Gal-TII or -TIII did not contain more than two N-acetyllactosamine repeats, while the products by ␤4Gal-TI included those containing four and possibly five N-acetyllactosaminyl repeats (Fig. 1) . Considering that ␤4Gal-TI is widely distributed in various tissues (36, 42) , these results, taken together, indicate that ␤4Gal-TI is mainly responsible for poly-N-acetyllactosamine synthesis in N-glycans.
The present study also demonstrated that ␤4Gal-TIII and -TIV become less efficient in poly-N-acetyllactosamine synthesis when the acceptor contains more than one N-acetyllactosamine unit (Fig. 2, Table I ). Similarly, iGnT acts much less efficiently on Gal␤134GlcNAc␤133Gal␤134GlcNAc␤136-Man␣13 R than Gal␤134GlcNAc␤136 Man␣13 R (Fig. 3 , Table I ). a V max of iGnT is compared with the V max (97.8 nmol/h/ml) obtained using Gal␤1-4GlcNAc␤1-6Man␣1-6Man␤-octyl as an acceptor. b V max for ␤4Gal-Ts is compared to the V max (118.3 nmol/h/ml) obtained for ␤4Gal-TI using GlcNAc␤1-6Man␣1-6Man␤-octyl as an acceptor. c These parameters could not be obtained due to substrate inhibition. These results suggest that the di-N-acetyllactosaminyl structure may have a different conformation from mono-N-acetyllactosaminyl structure and such a different conformation is not favorable for the action of iGnT, ␤4Gal-TIII, and ␤4Gal-TIV. These results are consistent with the fact that two N-acetyllactosamine units can be detected more widely than three Nacetyllactosamine units in a variety of glycoproteins (43) (44) (45) (46) (47) . In particular, there are only a few cases where soluble glycoproteins contain three or more N-acetyllactosamine units (see, for example, Ref. 48) . This is exemplified by human recombinant erythropoietin produced in Chinese hamster ovary cells. In that case, the majority of the recombinant erythropoietin was found to contain two N-acetyllactosamine units, and only less than 5% contained three N-acetyllactosamine units in a side chain (44 -46) .
The present study demonstrated that iGnT decreases its efficiency as an acceptor contains more N-acetyllactosamine repeats (Fig. 3) . In contrast, ␤4Gal-TI only marginally decreases its efficiency when acceptors contain increasing numbers of N-acetyllactosamine repeats (Fig. 2A) . These results indicate that the action of iGnT is probably a rate-limiting step for poly-N-acetyllactosamine synthesis in N-glycans, although there are other factors that control poly-N-acetyllactosamine synthesis.
First, it has been shown recently that a branched GlcNAc-␤136(GlcNAc␤132)Man␣136Man␤13 R structure serves as a much better acceptor than an unbranched GlcNAc␤136-Man␣136Man␤13 R or GlcNAc␤132Man␣136Man␤13 R (31). This is probably due to the acquisition of a favorable conformation for iGnT and ␤4Gal-TI by having the branched structure (49) . Second, it has been demonstrated that membrane glycoproteins contain more and longer poly-N-acetyllactosamines than soluble, secretory glycoproteins (50) . This may be due to the fact that iGnT has a shorter transmembrane domain than many other glycosyltransferases (29) . Third, it is necessary for glycoproteins to move slowly through the Golgi apparatus for poly-N-acetyllactosamine synthesis (51). Otherwise, the formation of N-acetyllactosamine is immediately followed by sialylation or other modifications that prevent further addition of N-acetyllactosamine. In addition, it appears that only selected numbers of glycoproteins are enriched with poly-N-acetyllactosamines. For example, Lamp-1 and Lamp-2 are always the major carriers for poly-N-acetyllactosamines in various cells (52) (53) (54) . It is possible that Lamp-1 and Lamp-2 satisfy all of the criteria mentioned above.
It has been demonstrated that core 2-branched O-glycans contained shorter and fewer N-acetyllactosamine repeats than N-glycans when O-glycans and N-glycans were analyzed in the same Lamp molecules (52) (53) (54) (55) or the same Chinese hamster ovary cells (43, 56) . This is probably due to the intrinsic nature of ␤4Gal-TIV, which acts less efficiently on longer poly-Nacetyllactosamine units, as shown in synthetic substrates utilized in the present study and lacto-series glycolipids (28) . In the present study, we demonstrated that core 4-branched Oglycans are galactosylated by ␤4Gal-TI but are even less efficient acceptors for poly-N-acetyllactosamine formation than core 2-branched O-glycans (Figs. 5 and 7) .
It is possible that a galactosylated substrate, GlcNAc␤136-(Gal␤134 GlcNAc␤133)GalNAc is a less favorable acceptor for ␤4Gal-Ts, as seen for galactosylation of Gal␤134GlcNAc␤-136(GlcNAc␤133)GalNAc (Table II) . More importantly, core 4-branched Gal␤134GlcNAc␤136(GlcNAc␤133)GalNAc is a less favorable substrate for iGnT than core 2-branched Gal␤134GlcNAc␤136 (Gal␤133)GalNAc (Fig. 6) . This is probably due to competition between the GlcNAc residue in the core 4 acceptor and UDP-GlcNAc. Since similar competition takes place in galactosylation of core 4-branched oligosaccharides, as described above, these results suggest that poly-Nacetyllactosaminyl extension of core 4-branched oligosaccharides faces two obstacles. This is most likely the reason why core 4-branched oligosaccharides acquired a lesser amount of N-acetyllactosaminyl extension than core 2-branched oligosaccharides (Fig. 5) .
It is noteworthy that a similar substrate inhibition also plays a role in various aspects of poly-N-acetyllactosamine synthesis. Previously, we have shown that galactosylation of core FIG. 7 . Proposed biosynthetic pathways of core 2-and core 4-branched O-glycans. ␣-N-Acetylgalactosamines are transferred to serine or threonine residues in a polypeptide by ␣-N-acetylgalactosaminyltransferase (␣GalNAc-T). This is followed by the action of core 1 ␤1,3-galactosyltransferase (␤3Gal-T), forming Gal␤133GalNAc␣13 R (core 1). Core 1 is then converted to GlcNAc␤136(Gal␤133)GalNAc␣13 R (core 2) by core 2 ␤1,6-N-acetylglucosaminyltransferase (C2GnT) and then Gal␤134GlcNAc␤136(Gal␤133)GalNAc␣13 R by ␤4Gal-TIV. Poly-Nacetyllactosamines will be added on galactosylated core 2 by alternate actions of iGnT and ␤4Gal-TIV. Alternatively, GalNAc␣13 R can be extended by core 3 ␤1,3-N-acetylglucosaminyltransferase (␤3GlcNAc-T), forming GlcNAc␤133GalNAc␣13 R (core 3). This will be followed by core 4 ␤1,6-N-acetylglucosaminyltransferase (C4GnT) to form GlcNAc␤136(GlcNAc␤133)GalNAc␣13 R (core 4). Core 4 is galactosylated by ␤4Gal-TI, resulting in Gal␤134GlcNAc␤136(Gal␤134GlcNAc␤133)GalNAc␣13 R. Poly-N-acetyllactosamines will be added by alternate actions of iGnT and ␤4Gal-TI. The cDNAs encoding C2GnT (20) , C4GnT (C2/C4/IGnT) (25, 26) , and ␣GalNAc-T (for example, see Ref. 60 ) have been published. The cDNAs encoding core 1 forming ␤3Gal-T and core 3 forming ␤3GlcNAc-T have not been published.
2-branched oligosaccharides displays a typical substrate inhibition except for ␤4Gal-TIV (27) . In I branch formation (30) , the GlcNAc␤136 branch in the Gal␤134GlcNAc␤133(GlcNAc␤-136)Gal␤13 R structure is very inefficient for galactosylation, resulting in short I branches as seen in human erythrocytes (57) . This inefficiency can be also explained by competition between the Gal terminal in the linear side chain and UDP-Gal for ␤4Gal-TI. These results, combined together, indicate that an acceptor gains different properties immediately after galactosylation or N-acetyllactosaminylation takes place. Such a conversion apparently plays a significant role in controlling poly-N-acetyllactosamine synthesis.
The results, obtained in the present study and the previous study (27) , indicate that mucin-type O-glycans contain shorter and fewer poly-N-acetyllactosamines extended from core 2 or core 4 branches. Mucin-type O-glycans also include N-acetyllactosamine extension from core 1 oligosaccharides, forming Gal␤134GlcNAc␤133Gal␤133GalNAc (58, 59 ). This formation is dependent on a novel iGnT yet to be identified that adds N-acetylglucosamine to Gal␤133GalNAc. Future studies will be significant to identify such a novel iGnT by cloning its cDNA and determining how the poly-N-acetyllactosamine extension is regulated in core 1 oligosaccharides.
